Overlook Program Joins National Parkinson’s Disease Research Group

SUMMIT – The Atlantic Neuroscience Institute’s Movement Disorders Program has been named a new member of the Parkinson Study Group, a national research group that will offer a variety of new opportunities and resources to study Parkinson’s disease.

The Parkinson Study Group is a North American cooperative research group of experts in Parkinson’s disease that conducts large-scale clinical research studies in the illness. These studies often involve hundreds, sometimes thousands of patients in up to 70 centers. Founded in 1986, the PSG now includes more than 400 active investigators, coordinators and scientists from approximately 120 sites located throughout the United States and Canada.


The Movement Disorders Program, which offers specialized care for Parkinson’s Disease and other movement-related neurological problems such as Chorea and Huntington’s disease, tremor, dystonia, restless legs syndrome, and Tourette’s syndrome, is one of only three facilities in New Jersey that has been approved to be a member of the PSG.

“This membership will allow us to participate in some of the most cutting-edge and important research studies in Parkinson’s Disease,” said Roger Kurlan, MD, director of the Movement Disorders Program. “Being able to collaborate with other leaders in this field is a tremendous recognition of the work we do, and it fills us with excitement about the new opportunities we will have to further explore ways to help patients fight this disease.”

Parkinson’s Disease is a neurological disorder that occurs when nerve cells in the brain that create dopamine, which send signals that control movement, break down. It is estimated that the disease affects about one million people in the United States, and is expected to affect more as the proportion of Americans over the age of 55 grows.

The Movement Disorders Program at Atlantic Neuroscience Institute offers patients a variety of services to help identify and treat movement disorders including Botox therapy, imaging methods such as magnetic resonance imaging (MRI) and computed tomography (CT), neurosurgical deep brain stimulation (DBS) therapy, as well as surgery, counseling and medication. The program also conducts various studies, including a one starting this month which will examine whether the practice of Tai Chi affects the symptoms of Parkinson’s, and another studying a new drug for restless legs syndrome.

For more information about the Atlantic Neuroscience Institute and the Movement Disorder’s Program, visit www.atlantichealth.org. Call 908-522-6144 for patient appointments.

For more information about the Parkinson Study Group, visit http://www.parkinson-study-group.org/.

Connect with NJTODAY.NET

Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!
Email ads@njtoday.net for advertising information Send stuff to NJTODAY.NET Like Us On Facebook Follow Us On Twitter Download this week's issue of NJTODAY.NET
Print Friendly, PDF & Email